Director Bristol-Myers Squibb Company New Brunswick, New Jersey
Join Carl Allenspach and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “Transformative Technologies in Drug Delivery and Manufacturing”, that he is especially excited about.
M1230-10-54 3D-Printed Microneedles Delivering Regulatory Immune Cues to Antigen-Presenting Cells in the Skin Promote Immune Tolerance, Shrey A. Shah, MS, University of Maryland
M1330-07-39 Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines, Adelle Keys, Cytiva
M0930-06-35 Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption, Aakash Nathani, MS, Florida A&M University, Best Abstract Award winner
M0930-01-06 Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression, Zhanjie (Jason) Liu, Ph.D., Eli Lilly and Company
M1430-04-19 Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs), Joseph Fotsing, dsm-firmenich
